Form 4: Bicycle Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Michael Charles Ferguson Hannay, Chief Product & Supply Chain Officer of Bicycle Therapeutics plc, sold 257 ordinary shares to cover tax withholding obligations related to the vesting and settlement of RSUs.
Summary
- On April 11, 2024, Michael Charles Ferguson Hannay, the Chief Product & Supply Chain Officer of Bicycle Therapeutics plc, sold 257 ordinary shares of the company.
- The sale was executed to cover statutory tax withholding obligations associated with the vesting and settlement of Restricted Stock Units (RSUs).
- The shares were sold at a weighted average price of $22.49, with individual transactions ranging from $22.48 to $22.49.
- Following the transaction, Hannay directly owns 22,891 ordinary shares of Bicycle Therapeutics plc.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction (sale of shares to cover taxes) and doesn't suggest any underlying issues with the company. Therefore, the sentiment is neutral to slightly positive.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a routine practice among corporate executives and do not necessarily indicate a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 04/11/2024 | Date of the share sale transaction. |
| 04/12/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.